Volex plc earnings date
Volex plc (64K) Q4 2026 Earnings Report
DE:64K Q4 2026 EPS Results
- Actual EPS
- EUR 0.18
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- EUR 0.22
DE:64K Q4 2026 Revenue Results
- Actual Revenue
- EUR 588.91M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +10.03%
Earnings Announcement Details
- Quarter
- Q4 2026
- Date
- 06/25/2026
- Time
- Before Open
- Conference Call
- Thursday, June 25, 2026
Volex plc's next earnings date is estimated for July 1, 2027, based on past reporting schedules.
Q4 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2026 Earnings Call Summary
The call presents a strongly positive operational and financial performance: record revenue, substantial organic growth, margin expansion above guidance, doubled data center revenues, improved returns (ROCE 21%) and reduced leverage (0.8x). Management set an ambitious, clearly articulated medium-term plan to reach $2 billion revenue and 12% operating margin. Key risks were acknowledged—customer concentration in data centers, declines in Consumer Electricals and Medical (destocking), higher working capital, and some macro pressures (freight, inflation, FX), as well as residual selling related to the AIM-to-Main move and elevated acquisition valuations. Overall, the positives (robust growth, margin and cash/return metrics, strategic clarity and momentum) materially outweigh the identifiable challenges.
Volex's guidance set a clear medium‑term target to reach $2.0bn of revenue at a 12% underlying operating margin (implying roughly $240m of underlying operating profit), driven by about $500m of organic growth plus ~$300m from disciplined capability‑led acquisitions; this implies ~200bps of margin expansion from FY26's 10.2% (FY26 revenue $1.243bn, organic growth 14.2%, underlying operating profit $127.3m, underlying EBITDA $164m up 22%, ROCE 21%, underlying basic EPS $0.435 up 20%). Capital allocation priorities remain organic first, then selective M&A (post‑acquisition ROCE target ≥15% within two years and ~15% operating margin threshold), with typical capex of 3–4% of revenue (FY26 capex $35m, 2.8% of revenue; projects target <2‑year payback), cash conversion 63.9% (pre‑capex >90%), free cash flow $42m, and covenant leverage 0.8x. Near‑term guidance: trading into FY27 is “strong and in line” with expectations, data‑center demand was sustained into Q1 FY27, Medical should stabilise in FY27, and the company expects further margin improvement from site rationalisation and centres of excellence.
- Record Revenue and Strong Organic GrowthRevenue of $1.243 billion, up 14.4% year-on-year (organic growth 14.2%), delivering the five-year plan a full year early and surpassing the $1.2 billion target.
- Margin Expansion and Profitability ImprovementUnderlying operating profit of $127.3 million (≈ +20% YoY) and underlying operating margin improved to 10.2% from 9.8%, exceeding the prior 9%-10% guidance range.
- Strong Returns and Earnings Per ShareReturn on capital employed improved to 21%; underlying basic EPS was $0.435, up 20% year-on-year.
- Robust Cash Generation and EBITDA GrowthUnderlying EBITDA of $164 million, up 22% YoY; underlying free cash flow of $42 million (consistent with prior year); pre-capex cash conversion over 90%.
- Outstanding Complex Industrial / Data Center PerformanceComplex Industrial Technology grew organically 56.3% to $382.9 million, with data center revenue doubling year-on-year and sustained demand into FY 2027 Q1.
- Strong Off-Highway and EV ProgressOff-Highway organic growth 20% to $279.3 million driven by defense program wins and North American ramp; EV & Electrification organic growth 4.8% to $181.8 million with new integrated charging program contributions and adjacencies (energy storage).
- Financial Discipline and Capital PositionCapital expenditure of $35 million (2.8% of revenue), covenant leverage reduced to 0.8x (from 1.0x) providing headroom for growth and disciplined capital allocation priorities (organic growth, selective M&A, progressive dividend, share buybacks for incentives).
- Clear Medium-Term TargetsNew medium-term plan targeting ~$2 billion revenue and a 12% underlying operating margin (~200 bps margin expansion), with an expected mix of ~$500 million organic growth and ~$300 million from capability-led acquisitions.
DE:64K Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jul 01, 2027 | 2027 (Q4) | ―- | 0.18 | ― | ― |
| Nov 12, 2026 | 2027 (Q2) | ―0.25 | 0.18 | 40.31% (+0.07) | |
| Jun 25, 2026 | 2026 (Q4) | ―0.18 | 0.22 | -18.38% (-0.04) | |
| Nov 12, 2025 | 2026 (Q2) | 0.190.18 | 0.14 | 29.80% (+0.04) | |
| Jun 26, 2025 | 2025 (Q4) | 0.170.17 | 0.1 | 72.90% (+0.07) | |
| Nov 15, 2024 | 2025 (Q2) | 0.160.14 | 0.16 | -15.17% (-0.02) | |
| Jun 26, 2024 | 2024 (Q4) | ―0.13 | 0.13 | -0.93% (-0.00) | |
| Nov 23, 2023 | 2024 (Q2) | ―0.16 | 0.12 | 29.93% (+0.04) | |
| Jun 22, 2023 | 2023 (Q4) | ―0.13 | 0.07 | 74.19% (+0.06) | |
| Nov 09, 2022 | 2023 (Q2) | ―0.12 | 0.12 | 5.38% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

